Skip to Content

The recent announcement by 23andMe, stating it now has FDA authorization to report on three specific BRCA1 and BRCA2 breast cancer gene mutations associated with breast, ovarian and prostate cancer via direct-to-consumer (DTC) testing, stirred up debate. Since reading about this announcement, I’ve been mulling over my thoughts on it. 

Read More about FDA Will Allow 23andMe to Offer DTC Test for Three BRCA Gene Mutations – Good or Bad Idea?

Most breast cancers are not hereditary, but rather are considered sporadic. The latter is not the case in my family. When hereditary cancer impacts YOUR family, it’s a huge deal because suddenly, it’s not just about you. If you’ve been reading Nancy’s Point for a while, you know I generally don’t talk about my family …

Read More about When Your Family Is Impacted by Hereditary Cancer – An Interview with My Sister